Identification of a new MAGE gene with tumor-specific expression by representational difference analysis

Cancer Research

Volumn 58, Issue 4, 1998, Pages 743-752

  Lucas, Sophie ^a,c   De Smet, Charles ^a   Arden, Karen C ^b   Viars, Carrie S ^b   Lethé, Bernard ^a   Lurquin, Christophe ^a   Boon, Thierry ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c FNRS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

AMINO ACID SEQUENCE; ARTICLE; CELL PROLIFERATION; GENE LOCATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSFECTION; GERM CELL; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; TISSUE SPECIFICITY;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; BASE SEQUENCE; DNA, COMPLEMENTARY; GENE EXPRESSION; GENE LIBRARY; HUMANS; MALE; MELANOMA; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; REPETITIVE SEQUENCES, NUCLEIC ACID; SEQUENCE ALIGNMENT; TESTIS; X CHROMOSOME;

EID: 0032520067     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Boon, T., Cerottini, J-C., Van den Eynde, B., van der Bruggen, P., and Van Pel, A. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol., 12: 337-365, 1994.
2. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma Science (Washington DC), 254: 1643-1647, 1991.
3. De Plaen, E., Arden, K., Traversari, C., Gaforio, J. J., Szikora, J-P., De Smet, C., Brasseur, F., van der Bruggen, P., Lethé, B., Lurquin, C., Brasseur, R., Chomez, P., De Backer, O., Cavenee, W., and Boon, T. Structure, chromosomal localization and expression of twelve genes of the MAGE family. Immunogenetics, 40: 360-369, 1994.
4. Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethé, B., Brasseur, F., and Boon, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med., 179: 921-930, 1994.
5. van der Bruggen, P., Szikora, J-P., Boël, P., Wildmann, C., Somville, M., Sensi, M., and Boon, T. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601. Eur. J. Immunol., 24: 2134-2140, 1994.
6. van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P. G., Boël, P., De Smet, C., Traversari, C., Townsend, A., and Boon, T. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol., 24: 3038-3043, 1994.
7. Boël, P., Wildmann, C., Sensi. M-L., Brasseur, R., Renauld, J-C., Coulie, P., Boon, T., and van der Bruggen, P. BAGE, a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity, 2: 167-175, 1995.
8. Van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B , Lucas, S., and Boon, T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med., 182: 689-698, 1995.
9. Brichard, V., Van Pel, A., Wölfel, T., Wölfel, C., De Plaen, E., Lethé, B., Coulie, P., and Boon, T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 178: 489-495, 1993.
10. Wölfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Meyer zum Büschenfelde, K-H., and Boon, T. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol., 24: 759-764, 1994.
11. Coulie, P. G., Brichard, V., Van Pel, A., Wölfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J-P., Renauld, J-C., and Boon, T. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 180: 35-42, 1994.
12. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E., and Rosenberg, S. A. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med., 180: 347-352, 1994.
13. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., and Rosenberg, S. A. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA, 91: 6458-6462, 1994.
14. Bakker, A. B. H., Schreurs, M. W. J., de Boer, A. J., Kawakami, Y., Rosenberg, S. A., Adema, G. J., and Figdor, C. G. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med., 179: 1005-1009, 1994.
15. Cox, A. L., Skipper, J., Chen, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard, V. H., Hunt, D. F., and Slingluff, C. L., Jr. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science (Washington DC), 264: 716-719, 1994.
16. Wang, R-F., Robbins, P. F., Kawakami, Y., Kang, X-Q., and Rosenberg, S. A. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J. Exp. Med., 181: 799-804, 1995.
17. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science (Washington DC), 269: 1281-1284, 1995.
18. Coulie, P. G., Lehmann, F., Lethé, B., Herman, J., Lurquin, C., Andrawiss, M., and Boon, T. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl. Acad. Sci. USA, 92: 7976-7980, 1995.
19. Robbins, P. F., El-Gamil, M., Li, Y. F., Kawakami, Y., Loftus, D., Appella, E., and Rosenberg, S. A. A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med., 183: 1185-1192, 1996.
20. Brändie, D., Brasseur, F., Weynants, P., Boon, T., and Van den Eynde, B. A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma. J. Exp. Med., 183: 2501-2508, 1996.
21. Mandruzzato, S., Brasseur, F., Andry, G., Boon, T., and van der Bruggen, P. A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. J. Exp. Med., 186: 785-793, 1997.
22. Fisk, B., Blevins, T. L., Wharton, J. T., and Ioannides, C. G. Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumorspecific cytotoxic T lymphocytes lines. J. Exp. Med., 181: 2109-2117, 1995.
23. Takahashi, K., Shichijo, S., Noguchi, M., Hirohata, M., and Itoh, K. Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res., 55: 3478-3482, 1995.
24. Lisitsyn, N., Lisitsyn, N., and Wigler, M. Cloning the differences between two complex genomes. Science (Washington DC), 259: 946-951, 1993.
25. Hubank, M., and Schatz, D. G. Identifying differences in mRNA expression by representational difference analysis of cDNA., Nucleic Acids Res., 22: 5640-5648, 1994.
26. Lehmann, F., Marchand, M., Hainaut, P., Pouillart, P., Sastre, X., Ikeda, H., Boon, T., and Coulie, P. G. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur. J. Immunol., 25: 340-347, 1995.
27. Davis, L. G., Dibner, M. D., and Battey, J. F. Preparation and analysis of RNA from eukaryotic cells. In: L. G. Davis, M. D. Dibner, and J. F. Battey (eds.) Basic Methods in Molecular Biology, pp. 130-135. New York: Elsevier, 1986.
28. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
29. Henikoff, S. Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing. Gene (Amst.), 28: 351-359, 1984.
30. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. Basic local alignment search tool. J. Mol. Biol., 215: 403-10, 1990.
31. Kermouni, A., Van Roost, E., Arden, K. C., Vermeesch, J. R., Weiss, S., Godelaine, D., Flint, J., Lurquin, C., Szikora, J-P., Higgs, D. R., Marynen, P., and Renauld, J-C. The IL-9 receptor gene (IL9R): genomic structure, chromosomal localization in the pseudoautosomal region of the long arm of the sex chromosomes, and identification of IL9R pseudogenes at 9qter, 10pter, 16pter, and 18pter. Genomics, 29: 371-382, 1995.
32. Weynants, P., Lethé, B., Brasseur, F., Marchand, M., and Boon, T. Expression of MAGE genes by non-small-cell lung carcinomas. Int. J. Cancer., 56: 826-829, 1994.
33. Jacky, P. B. The ACT Cytogenetics Laboratory Manual, p. 89. New York: Raven Press, 1991.
34. Pinkel, D., Straume, T., and Gray, J. W. Cytogenetic analysis using quantitative, high-sensitivity fluorescence hybridization. Proc. Natl. Acad. Sci. USA, 83: 2934-2938, 1986.
35. Lemieux, N., Dutrillaux, B., and Viegas-Péquignot, E. A simple method for simultaneous R-or G-banding and fluorescence in situ hybridization of small single copy genes. Cytogenet. Cell Genet., 59: 311-312, 1992.
36. Walter, A. M., Spillet, D. J., Thomas, P., Weissenbach, J., and Goodfellow, P. N. A method for constructing radiation hybrid maps of whole genomes. Nat. Genet., 7: 22-28, 1994.
37. De Smet, C., De Backer, O., Faraoni, I., Lurquin, C., Brasseur, F., and Boon, T. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc. Natl. Acad. Sci. USA, 93: 7149-7153, 1996.
38. De Smet, C., Courtois, S. J., Faraoni, I., Lurquin, C., Szikora, J-P., De Backer, O., and Boon, T. Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene. Immunogenetics, 42: 282-290, 1995.
39. De Plaen, E., Naerhuyzen, B., De Smet, C., Szikora, J-P., and Boon, T. Alternative promoters of gene MAGE4a. Genomics, 40: 305-313, 1997.
40. Lurquin, C., De Smet, C., Brasseur, F., Muscatelli, F., Martelange, V., De Plaen, E., Brasseur, R., Monaco, A. P., and Boon, T. Two members of the human MAGE-B gene family located IN Xp21.3 are expressed in tumors of various histological origins, Genomics, in press, 1998.
41. Parker, K. C., Bednarek, M. A., and Coligan, J. E. Scheme for ranking potential HLAA2 binding peptides based on independent binding of individual peptide sidechains. J. Immunol., 152: 163-175, 1994.
42. Sahin, U., Tureci, O., Schmitt, H., Cochlovius, B., Johannes, T., Schmits, R., Stenner, F., Luo, G., Schobert, I., and Pfreundschuh, M. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA, 92: 11810-11813, 1995.
43. Dabovic, B., Zanaria, E., Bardoni, B., Lisa, A., Bordignon, C., Russo, V., Matessi, C., Traversari, C., and Camerino, G. A family of rapidly evolving genes from the sex reversal critical region in Xp21 Mamm. Genome, 6: 571-580, 1995.
44. Muscatelli, F., Walker, A. P., De Plaen, E., Stafford, A. N., and Monaco, A. P. Isolation and characterization of a new MAGE gene family in the Xp21.3 region. Proc. Natl. Acad. Sci. USA, 92: 4987-4991, 1995.
45. Rogner, U. C., Wilke, K., Steck, E., Korn, B., and Poustka, A. The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28. Genomics, 29: 725-731, 1995.
46. Boguski, M. S., and Schuler, G. D. Establishing a human transcript map. Nat. Genet., 10: 369-371, 1995.
47. De Backer, O., Verheyden, A-M., Martin, B., Godelaine, D., De Plaen, E., Brasseur, R., Avner, P., and Boon, T. Structure, chromosomal location, and expression pattern of three mouse genes homologous to the human MAGE genes. Genomics, 28: 74-83, 1995.
48. Wootton, J. C. Sequences with "unusual" amino acid compositions. Curr. Opin. Struct. Biol., 4: 413-421, 1994.
49. Lichter, J. B., Barr, C. L., Kennedy, J. L., Van Tol, H. H. M., Kidd, K. K., and Livak, K. J. A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum. Mol. Genet., 2: 767-773, 1993.
50. Ebstein, R. P., Novick, O., Umansky, R., Priel, B., Osher, Y., Blaine, D., Bennett, E. R., Nemanov, L., Katz, M., and Belmaker, R. H. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nat. Genet., 12: 78-80, 1996.
51. Rammensee, H-G., Friede, T., and Stevanovic, S. MHC ligands and peptide motifs: first listing. Immunogenetics., 41: 178-228, 1995.
52. Celis, E., Tsai, V., Crimi, C., DeMars, R., Wentworth, P. A., Chesnut, R. W., Grey, H. M., Sette, A., and Serra, H. M. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA, 91: 2105-2109, 1994.
53. Hill, A. V. S., Elvin, J., Willis, A. C., Aidoo, M., Allsopp, C. E. M., Gotch, F. M., Gao, X. M., Takiguchi, M., Greenwood, B. M., Townsend, A. R. M., and McMichael, A. J. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature (Lond.), 360: 434-439, 1992.
54. Houbiers, J. G. A., Nijman, H. W., van der Burg, S. H., Drijfhout, J. W., Kenemans, P., van de Velde, C. J. H., Brand, A., Momburg, F., Kast, M. W., and Melief, C. J. M., In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53. Eur. J. Immunol., 23: 2072-2077, 1993.
55. Herman, J., van der Bruggen, P., Luescher, I., Mandruzzato, S., Romero, P., Thonnard, J., Fleischhauer, K., Boon, T., and Coulie, P. G. A peptide encoded by human gene MAGE-3 and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Immunogenetics, 43: 377-383, 1996.